MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwarzer, C.
Right arrow Articles by Sperk, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwarzer, C.
Right arrow Articles by Sperk, G.

Vol. 53, Issue 1, 6-13, January 1998

Up-Regulation of Neuropeptide Y-Y2 Receptors in an Animal Model of Temporal Lobe Epilepsy

Christoph Schwarzer, Nikolaus Kofler and Günther Sperk

Department of Pharmacology, University of Innsbruck, 6020 Innsbruck, Austria

Receptor autoradiography with the Y2 receptor ligand 125I-peptide YY3-36 and in situ hybridization were applied to investigate changes in neuropeptide tyrosine-Y2 receptor expression after kainic acid-induced recurrent seizures in the rat hippocampus. In the strata oriens and radiatum of CA1 to CA3, which are densely innervated by Y2 receptor-bearing Schaffer collateral terminals, a transient 2-fold increase in Y2 receptor affinity was observed after 4-12 hr, with a later slow decline. No change was seen in Y2 mRNA expression in CA2/CA3 pyramidal cells, from which Schaffer collaterals originate. Conversely, in granule cells of the dentate gyrus, markedly elevated Y2 mRNA concentrations were observed (by 740% in the dorsal hippocampus) 24-48 hr after kainate injection. At the same time, a marked and lasting (up to 6 months) increase in the number of Y2 receptor sites (by 800%) was seen in the dentate hilus, which is innervated densely by mossy fibers. The early increase in Y2 receptor affinity in Schaffer collaterals was accompanied by a 60% decrease in the EC50 of peptide YY3-36 in inhibiting K+-stimulated glutamate release in hippocampal slices from kainic acid-treated rats. Our data indicate transient up-regulation of presynaptic Y2 receptors in Schaffer collaterals by a change in affinity and a permanent de novo synthesis of presynaptic Y2 receptors in granule cells/mossy fibers. These changes may cause augmented presynaptic inhibition of glutamate release from different hippocampal sites and, in conjunction with increased concentrations of neuropeptide tyrosine in mossy fibers, may represent an endogenous reactive anticonvulsant mechanism.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
B. Tu, O. Timofeeva, Y. Jiao, and J. V. Nadler
Spontaneous Release of Neuropeptide Y Tonically Inhibits Recurrent Mossy Fiber Synaptic Transmission in Epileptic Brain
J. Neurosci., February 16, 2005; 25(7): 1718 - 1729.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Karl, S. Lin, C. Schwarzer, A. Sainsbury, M. Couzens, W. Wittmann, D. Boey, S. von Horsten, and H. Herzog
Y1 receptors regulate aggressive behavior by modulating serotonin pathways
PNAS, August 24, 2004; 101(34): 12742 - 12747.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Richichi, E.-J. D. Lin, D. Stefanin, D. Colella, T. Ravizza, G. Grignaschi, P. Veglianese, G. Sperk, M. J. During, and A. Vezzani
Anticonvulsant and Antiepileptogenic Effects Mediated by Adeno-Associated Virus Vector Neuropeptide Y Expression in the Rat Hippocampus
J. Neurosci., March 24, 2004; 24(12): 3051 - 3059.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Sainsbury, C. Schwarzer, M. Couzens, and H. Herzog
Y2 Receptor Deletion Attenuates the Type 2 Diabetic Syndrome of ob/ob Mice
Diabetes, December 1, 2002; 51(12): 3420 - 3427.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Sainsbury, C. Schwarzer, M. Couzens, S. Fetissov, S. Furtinger, A. Jenkins, H. M. Cox, G. Sperk, T. Hokfelt, and H. Herzog
Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice
PNAS, June 25, 2002; 99(13): 8938 - 8943.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Furtinger, S. Pirker, T. Czech, C. Baumgartner, G. Ransmayr, and G. Sperk
Plasticity of Y1 and Y2 Receptors and Neuropeptide Y Fibers in Patients with Temporal Lobe Epilepsy
J. Neurosci., August 1, 2001; 21(15): 5804 - 5812.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. R. Patrylo, A. N. van den Pol, D. D. Spencer, and A. Williamson
NPY Inhibits Glutamatergic Excitation in the Epileptic Human Dentate Gyrus
J Neurophysiol, July 1, 1999; 82(1): 478 - 483.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics